Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
May 16, 2017 11:01 am UTC| Business
SALT LAKE CITY, May 16, 2017 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the U.S. commercial launch of its Bordetella Direct Test and its receipt of CE Marking...
May 16, 2017 11:01 am UTC| Business
OLNEY, Md., May 16, 2017 -- Sandy Spring Bancorp, Inc. (Nasdaq:SASR) (“Sandy Spring”), the parent company of Sandy Spring Bank, and WashingtonFirst Bankshares, Inc. (Nasdaq:WFBI) (”WashingtonFirst”), the parent company...
May 16, 2017 11:01 am UTC| Business
OLNEY, Md., May 16, 2017 -- Sandy Spring Bancorp, Inc. (Nasdaq:SASR) (“Sandy Spring”), the parent company of Sandy Spring Bank, and WashingtonFirst Bankshares, Inc. (Nasdaq:WFBI) (”WashingtonFirst”), the parent company...
Mitek Joins Airbnb, Lyft, Payfone and One World on Panel at K(NO)W Identity Conference
May 16, 2017 11:01 am UTC| Business
SAN DIEGO, Calif. and LONDON, May 16, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader inmobile captureand identity verification software solutions, announced that General Manager, Sarah Clark, will...
Mitek Joins Airbnb, Lyft, Payfone and One World on Panel at K(NO)W Identity Conference
May 16, 2017 11:01 am UTC| Business
SAN DIEGO, Calif. and LONDON, May 16, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader inmobile captureand identity verification software solutions, announced that General Manager, Sarah Clark, will...
Antares Pharma Announces Poster Presentation at the American Urological Association Annual Meeting
May 16, 2017 11:01 am UTC| Business
EWING, N.J., May 16, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) announced that data from its Phase 3 study of the pharmacokinetics and safety of subcutaneous testosterone enanthate delivered through the QuickShot® auto...
Antares Pharma Announces Poster Presentation at the American Urological Association Annual Meeting
May 16, 2017 11:01 am UTC| Business
EWING, N.J., May 16, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) announced that data from its Phase 3 study of the pharmacokinetics and safety of subcutaneous testosterone enanthate delivered through the QuickShot® auto...